500105 MilliporeOxytetracycline, Hydrochloride - CAS 2058-46-0 - Calbiochem
An antimicrobial agent. A member of the tetracycline family that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.
More>> An antimicrobial agent. A member of the tetracycline family that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Less<<Synonyms: OTC
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
2058-46-0 | C₂₂H₂₄N₂O₉ · HCl |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
500105-100GM |
|
Glass bottle | 100 gm |
|
— | |
500105-10GM |
|
Plastic ampoule | 10 gm |
|
— |
References | |
---|---|
References | Hardman, J.G., et al. 1996. in Goodman and Gilman’s The Pharmacological Basis of Therapeutics, Ninth Edition. pp. 1123 - 1125. McGraw-Hill Companies, New York. |
Product Information | |
---|---|
CAS number | 2058-46-0 |
Form | Yellow solid |
Hill Formula | C₂₂H₂₄N₂O₉ · HCl |
Chemical formula | C₂₂H₂₄N₂O₉ · HCl |
Optical rotation | Optical rotation: -190° to -200°(α 20 / d; c = 1, in 0.1 M HCl; anhydrous basis). |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥95% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | QI8225000 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
500105-100GM | 04055977199338 |
500105-10GM | 04055977199321 |
Documentation
Oxytetracycline, Hydrochloride - CAS 2058-46-0 - Calbiochem SDS
Title |
---|
Oxytetracycline, Hydrochloride - CAS 2058-46-0 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
500105 |
References
Reference overview |
---|
Hardman, J.G., et al. 1996. in Goodman and Gilman’s The Pharmacological Basis of Therapeutics, Ninth Edition. pp. 1123 - 1125. McGraw-Hill Companies, New York. |